THERMO FISHER SCIENTIFIC INC.
About THERMO FISHER SCIENTIFIC INC.
Thermo Fisher Scientific Inc. is a multinational leader in scientific instrumentation, reagents, consumables, software, and services for life sciences research, diagnostics, and applied markets. It serves pharmaceutical and biotech firms, hospitals, universities, research institutions, and government agencies worldwide. The company operates through four primary segments: Life Science Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Investors
Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.
Key highlights
- Rule 144 filing of $1,999,959.95 executed as public equity transaction.
- Headquartered in Waltham, MA with global operations across life sciences.
- Serves pharmaceutical, biotech, clinical, and academic customers via four business segments.
- No venture investors disclosed; filing represents securities sale not startup raise.
Ask StreetZero about THERMO FISHER SCIENTIFIC INC.
Put our AI to work on this deal.
Similar companies
Other Public Equity (NYSE) deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account